Astrana Health, Inc. (ASTH)

Astrana Health topped EPS expectations while revenue came in line in the second fiscal quarter of 2026, reported August 6, 2026, with EPS of $0.40 topping the $0.34 estimate (+19%) as revenue of $972.5 million came in line with the $982.2 million estimate (-0.99%). Revenue rose 48.5% to about $972.5 million from roughly $654.8 million a year ago, reflecting contributions across its Care Partners, Care Delivery, and Care Enablement model. Profitability metrics for the quarter included gross profit of about $104.0 million with gross margin at roughly 11%, and operating income of around $34.3 million with operating margin near 4%. Net income climbed 109.5% to about $19.7 million, up from roughly $9.4 million a year earlier, alongside EPS up 110.5% from $0.19. The company generated operating cash flow of about $100.8 million and repurchased roughly $4.4 million of stock during the quarter. For the next period, consensus calls for EPS of $0.42 on revenue of $1.020 billion.